A 101-page report said Fiorello had earned money from Pfizer while serving on a panel that chose what drugs would be used and that he improperly took money from Janssen and Duquesne University. The Commission fined him $27,000.
An April 2002 company publication showed that Janssen knew exactly what it was paying for. Under Faculty Bio, Janssen described Fiorello as being "responsible for the formulation of policies and procedures for drug use for ten state hospitals and facilities including the development and implementation of the PENNMAP project."
Flynn & Hogan - Expert Consensus
So where does TeenScreen fit in here? After all, it insists on its web site that it is absolutely not involved with this list business.
Well low and behold, that's not quite true. Just look what my talented records researcher, Sue Weibert, discovered in "The Journal of Clinical Psychiatry," Vol 60, 1999 Supplement 11: under Expert Consensus Guideline Series: Treatment of Schizophrenia 1999.
Here we have none other than Laurie Flynn listed as an "expert" who took part in creating the list. She surely must have forgotten about this.
Flynn and her band of pushers from the National Alliance for the Mentally Ill (NAMI) must be geniuses when it comes to picking drugs because 39 members of NAMI got to cast votes in determining which drugs could be on this list. The only group with more votes than NAMI was academic experts with 42 votes.
Another "expert" who took part in this "expert consensus" process was Flynn's good buddy, Mr Mike Hogan.
On its web site, TeenScreen claims that it does not endorse any specific drugs. Well the author obviously did not check with its Executive Director because she sure does.
Surprise, surprise! "Experts" Flynn and Hogan recommended the most expensive drugs on the market for the treatment of schizophrenia: Risperdal, Seroquel, and Zyprexa.
No affiliation with drug companies either huh? According to the report, "This project was supported by unrestricted educational grants from Eli Lilly and Co; Janssen Pharmaceutica, Inc; Novartis Pharmaceuticals Corporation; Ortho-McNeil Pharmaceutical; Pfizer, Inc; Zeneca Pharmaceuticals."
The truth is, NAMI is pharma's main front group and is used to implement every marketing scheme the industry dreams up. As its former Executive Director, Flynn was its top pusher for 16 years. The group even admits that its goal is to help pharma "grow the market," in an excerpt from the its 2000 990 entitled, "Guidelines for the Relationship between NAMI and the Campaign's Founding Sponsors."
Providers, health plans, and pharmaceutical companies want to grow their markets and to increase their share of the market. A. NAMI will cooperate with these entities to grow the market by making persons aware of the issues involving severe brain disorders, by giving professionals and providers the NAMI perspective, by bringing into treatment persons who are not being served, and by helping persons to adhere to their treatment plans. (2000 990 is available at Guidestar.com).
On March 2, 2004, Flynn testified at a congressional hearing that in the screening process, "youth complete a 10-minute self-administered questionnaire that screens for social phobia, panic disorder, generalized anxiety disorder, major depression, alcohol and substance abuse.
This is amazing, if Flynn is right, all it takes is ten minutes and a paper and pencil to unearth any one of 30 deep-seeded mental illnesses. I'm surprised they haven't figured out a way to cut out the middle-man doctor and set up a drive through for kids to go pick up their pills at Walgreens without a prescription. That's probably in the works.
Experts warn that TeenScreen will do more harm than good. "It is impossible, on cursory examination, or on the basis of the Program's brief written screening test, to detect suicidality or "mental illness," however we define it. Indeed, the fears evoked by the process of seeking out mental illness can create psychiatric symptoms," according to Dr Nathaniel Lehrman, MD, former Clinical Director, Kingsboro Psychiatric Center, Brooklyn NY; former Assistant Clinical Professor of Psychiatry, Albert Einstein and SUNY Downstate Colleges of Medicine.
An April 2002 company publication showed that Janssen knew exactly what it was paying for. Under Faculty Bio, Janssen described Fiorello as being "responsible for the formulation of policies and procedures for drug use for ten state hospitals and facilities including the development and implementation of the PENNMAP project."
Flynn & Hogan - Expert Consensus
So where does TeenScreen fit in here? After all, it insists on its web site that it is absolutely not involved with this list business.
Here we have none other than Laurie Flynn listed as an "expert" who took part in creating the list. She surely must have forgotten about this.
Flynn and her band of pushers from the National Alliance for the Mentally Ill (NAMI) must be geniuses when it comes to picking drugs because 39 members of NAMI got to cast votes in determining which drugs could be on this list. The only group with more votes than NAMI was academic experts with 42 votes.
Another "expert" who took part in this "expert consensus" process was Flynn's good buddy, Mr Mike Hogan.
On its web site, TeenScreen claims that it does not endorse any specific drugs. Well the author obviously did not check with its Executive Director because she sure does.
Surprise, surprise! "Experts" Flynn and Hogan recommended the most expensive drugs on the market for the treatment of schizophrenia: Risperdal, Seroquel, and Zyprexa.
No affiliation with drug companies either huh? According to the report, "This project was supported by unrestricted educational grants from Eli Lilly and Co; Janssen Pharmaceutica, Inc; Novartis Pharmaceuticals Corporation; Ortho-McNeil Pharmaceutical; Pfizer, Inc; Zeneca Pharmaceuticals."
The truth is, NAMI is pharma's main front group and is used to implement every marketing scheme the industry dreams up. As its former Executive Director, Flynn was its top pusher for 16 years. The group even admits that its goal is to help pharma "grow the market," in an excerpt from the its 2000 990 entitled, "Guidelines for the Relationship between NAMI and the Campaign's Founding Sponsors."
Providers, health plans, and pharmaceutical companies want to grow their markets and to increase their share of the market. A. NAMI will cooperate with these entities to grow the market by making persons aware of the issues involving severe brain disorders, by giving professionals and providers the NAMI perspective, by bringing into treatment persons who are not being served, and by helping persons to adhere to their treatment plans. (2000 990 is available at Guidestar.com).
On March 2, 2004, Flynn testified at a congressional hearing that in the screening process, "youth complete a 10-minute self-administered questionnaire that screens for social phobia, panic disorder, generalized anxiety disorder, major depression, alcohol and substance abuse.
This is amazing, if Flynn is right, all it takes is ten minutes and a paper and pencil to unearth any one of 30 deep-seeded mental illnesses. I'm surprised they haven't figured out a way to cut out the middle-man doctor and set up a drive through for kids to go pick up their pills at Walgreens without a prescription. That's probably in the works.
Experts warn that TeenScreen will do more harm than good. "It is impossible, on cursory examination, or on the basis of the Program's brief written screening test, to detect suicidality or "mental illness," however we define it. Indeed, the fears evoked by the process of seeking out mental illness can create psychiatric symptoms," according to Dr Nathaniel Lehrman, MD, former Clinical Director, Kingsboro Psychiatric Center, Brooklyn NY; former Assistant Clinical Professor of Psychiatry, Albert Einstein and SUNY Downstate Colleges of Medicine.
Next Page 1 | 2 | 3 | 4 | 5 | 6
(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).
